Eucatex Announces Consolidated Earnings Results for the Third Quarter and Nine Months of 2017; Provides Capex Guidance for the Year 2017
For the nine months, the company reported gross revenue was BRL 1,061.4 million compared to BRL 1,029.1 million a year ago. Net revenue was BRL 887.1 million compared to BRL 859.9 million a year ago. Net income before financial result was BRL 78.9 million compared to BRL 67.9 million a year ago. Net income after financial result was BRL 39.7 million compared to BRL 25.9 million a year ago. Net income was BRL 39.7 million compared to BRL 22.5 million a year ago. Net cash flow from operating activities was BRL 94.6 million compared to BRL 51.8 million a year ago. Addition to fixed assets was BRL 35.2 million compared to BRL 35.7 million a year ago. Addition to biological assets was BRL 42.5 million compared to BRL 32.3 million a year ago. EBITDA adjusted by non-cash events was BRL 146.2 million compared to BRL 122.1 million a year ago. Recurring net income was BRL 46.7 million compared to BRL 39.5 million a year ago. Recurring adjusted EBITDA was BRL 153.2 million compared to BRL 139.1 million a year ago. EBIT was BRL 71.9 million compared to BRL 50.9 million a year ago. Net debt was BRL 332.5 million compared to BRL 306.8 million a year ago.
In 2017, the Company plans to reduce capex by about 12.8% in relation to 2016 (BRL 81.0 million), with the focus being on sustaining capex.